Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Benda Pharmaceutical announced the appointment of a third...
Yesterday, 3SBio shot 23% higher after an analyst for...
Ascenta Therapeutics of the US has struck a deal to...
For the first time in 29 years, the industry's most...
Simcere Pharma has filed an Investigational New Drug...
It's earnings season, and almost every day for the past...
Epitomics, the San Francisco-area biopharma with two...
Simcere Pharma was given SFDA approval to begin China...
Sinopharm Group will pay $198 million for a 60% stake in...
Apexigen, a California antibody company with strong...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
